Iterum Therapeutics Stock Price

0.0105 (4.38%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 841,677
Bid Price 0.245
Ask Price 0.25
News -
Day High 0.26


52 Week Range


Day Low 0.2341
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Iterum Therapeutics PLC ITRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0105 4.38% 0.25 19:30:11
Open Price Low Price High Price Close Price Prev Close
0.26 0.2341 0.26 0.25 0.2395
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,360 841,677 $ 0.2444096 $ 205,714 - 0.1852 - 2.52
Last Trade Time Type Quantity Stock Price Currency
19:40:07 formt 157 $ 0.25 USD


Draw Mode:

Iterum Therapeutics PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 45.84M 183.35M 180.89M $ - $ - -0.75 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -33.66k 0.60%

more financials information »

Iterum Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ITRM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.21630.260.18520.20912661,410,7860.033715.58%
1 Month0.28760.300.18520.24016781,117,543-0.0376-13.07%
3 Months0.340.470.18520.32698121,174,187-0.09-26.47%
6 Months0.540.54020.18520.40213521,826,417-0.29-53.7%
1 Year1.032.520.18521.075,772,343-0.78-75.73%
3 Years7.237.64990.18521.415,325,472-6.98-96.54%
5 Years12.7013.000.18521.434,036,259-12.45-98.03%

Iterum Therapeutics Description

Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Your Recent History
Iterum The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.